Skip to content
Screener

Bio-Rad Laboratories BIO Europe — Net Sales

Other geography segments

Asia Pacific
$110.4M+6.1%
Americas
$45.1M+13.3%

Similar metrics at other companies

Amcor logo
AMCREurope — Net Sales
$2.02B+127%
DCH
DCHEurope — Net Sales
$588.2M+201%
Sylvamo logo
SLVMEurope — Net Sales
$185.25M-7.5%
The Cooper Companies, Inc. logo
COOEurope — Net Sales
$341.6M+17.0%
Brady Corporation logo
BRCEurope — Net Sales
$130.06M+12.4%
Genuine Parts logo
GPCEurope — Net Sales
$1.08B+6.2%

Other financials

Income statement

See full
Revenue$592.1M+1.1%
Gross profit$309.4M+1.1%
Operating income$34.1M+43.9%
Net income-$527.1M-924%
EPS (diluted)-$19.55-954%

Balance sheet

See full
Cash & equivalents$509.0M-2.7%
Total debt$987.3M-28.4%
Total equity$6.9B+2.6%
Total assets$9.8B+2.8%

Cash flow

See full
Operating cash flow$108.1M-16.8%
CapEx$30.0M-12.8%
Free cash flow$78.1M-18.2%

Valuation

See full
Market cap$9.3B+30.0%
Enterprise value$9.78B+19.3%
P/E55.1×+32.7×
P/S3.6×+0.8×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin8.8%-3.1pp
Net margin6.5%+3.4pp
FCF margin13.8%-0.2pp

Returns & leverage

See full
Return on equity2.5%+1.3pp
Debt / equity0.1×-0.1×
Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:19 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000012208-26-000035
Line itemThree Months Ended / March 31, 2026Three Months Ended / March 31, 2025
United States$229.8$241.7
EMEA206.8199.8
APAC110.4104.1
Other (primarily Canada and Latin America)45.139.8
Total net sales$592.1$585.4

Item 1. Financial Statements (Unaudited)

FAQ

What is Bio-Rad Laboratories's europe — net sales?
Bio-Rad Laboratories (BIO) reported europe — net sales of $206.8M in Q1 2026.
How has Bio-Rad Laboratories's europe — net sales changed year-over-year?
Bio-Rad Laboratories's europe — net sales increased by 3.5% year-over-year, from $199.8M to $206.8M.
What is the long-term trend for Bio-Rad Laboratories's europe — net sales?
Over 4 years (2021 to 2025), Bio-Rad Laboratories's europe — net sales has grown at a -1.8% compound annual growth rate (CAGR), from $947M to $881.8M.
What does europe — net sales mean?
This metric represents the total revenue generated from the sale of clinical diagnostics and life science products within the European geographic region. It reflects the company's market penetration, demand for laboratory instruments and reagents, and overall commercial performance in this specific territory. Fluctuations in this figure indicate changes in regional market share, pricing strategies, or macroeconomic conditions affecting European healthcare and research sectors.

Ask your AI about Bio-Rad Laboratories's europe — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude